Delivery Order SPE2DB22D2206-SPE2DB25FHZ96
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,935.50 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packs of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not include a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,809.76 to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packs (30-count) on August 15, 2025. This firm fixed-price delivery order, with performance completion targeted for August 18, 2025, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $5,093.43 for Alvimopan 12 mg capsules (unit dose, 30-count packages) with a completion date of September 5, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive...
- The Defense Logistics Agency awarded a $5,167.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Alvimopan 12 mg capsule unit dose packets (30-count). This non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The delivery order represents a near-immediate fulfillment requirement typical of pharmaceutical supply chain operations...
- The Defense Logistics Agency awarded a $24,688.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsules (unit dose, 30-count packages) with an ultimate completion date of September 10, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a...
- The Defense Logistics Agency awarded a $4,959.12 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Alvimopan 12 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion date of August 8, 2025, and performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packages (30-count) on August 14, 2025, with a ceiling value of $26,853.88 and an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Department of Defense Medical Supply Chain awarded a $56,685.66 delivery order to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count) on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's pharmaceutical supply relationship with Defense Logistics Agency Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count), valued at $2,152.36 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,910.65 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count). The contract, which was competitively awarded with no set-aside designation, was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHZ96Delivery Order
The Defense Logistics Agency awarded a $11,346.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose capsules of Alvimopan 12 mg, with a completion date of July 23, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The product is being delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The current delivery order for Alvimopan, a medication used in postoperative care, exemplifies the ongoing pharmaceutical supply requirements fulfilled through this expansive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 7/22/25 |